Biosynex

Biosynex, founded in 2005 and headquartered in France, is a publicly traded company operating within the Medical Devices & Equipment and Manufacturing sectors. The company specializes in the development and distribution of high-value diagnostic products, serving European markets with innovative healthcare solutions. Its strategic focus on advanced diagnostics positions it as a key player in the region's healthcare ecosystem.

The company's product portfolio includes rapid diagnostic tests, women's health solutions, treatment monitoring tools, and medical assistance products. Biosynex maintains a competitive edge through a proactive intellectual property strategy, filing patents to establish its innovative position in biology and healthcare. Operating across 3 locations, Biosynex employs between 500 - 1,000 individuals. Meet Biosynex's team to gain insight into their operational structure and leadership.

With a reported revenue of $102.8M, Biosynex serves both business and consumer markets across Europe. Its specialized medical and diagnostic technologies emphasize screening, prevention, and monitoring. The company's commitment to developing market-specific solutions, including various diagnostic tests, molecular biology tools, and medical devices, underscores its role in advancing healthcare diagnostics.